Finance News – Sanofi
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Ceo
Investors
Shares
Tariffs
Stock
Stock Market
Crypto Assets
Cryptocurrency
Ethereum
Price
Markets
Xrp
Etf
Bse
Stablecoin
Blockchain
Investment
Ipo
Eth
Sec
Index
Solana
Trade
Inflation
Earnings
Interest Rates
Coinbase
Sensex
Revenue
Token
Wall Street
Nasdaq
China
Treasury
Nse
Federal Reserve
Traders
Bse Sensex
Nifty
Sp 500
Gold
Tesla
Investor
Economy
Profit
Digital Assets
Advance Metals
Short Sellers
Backlash
Surcharge
Usd Margined Contracts
Bailouts
Taxpayer Bailout
Datasite
Export Oriented
Generics
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
CNBC Business • Jun 09, 2025
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
Merck’s newly authorized RSV vaccine for infants is expected to impact the market by challenging established treatments, potentially influencing sales and market share among leadin...
Read Full Article →
Investopedia • Jun 02, 2025
Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover
The agreement for a multibillion-dollar acquisition by Sanofi has led to a notable increase in the market value of Blueprint Medicines shares.
Read Full Article →
Investopedia • May 22, 2025
Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi
The company's market value increased significantly after the announcement of its upcoming purchase by a major pharmaceutical firm, highlighting investor confidence in the potential...
Read Full Article →